Disclosure by Small Cap Network
"TGR Group LLC has been paid a fee of $25,000 and one million newly issued restricted shares by Biocurex for coverage of the company. Under SEC Rule 144, all one million issued restricted shares are now eligible for sale into the public market. "TGR Group has submitted the appropriate filings to sell the shares." In addition, on March 22, 2005, TGR entered into an extended agreement with Biocurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with Biocurex for an additional 100,000 shares of newly issued, restricted stock."
Quote from Small Cap Network's blurp on today's press release:
"Investors, potential or otherwise, should obviously take note, as the most recent evolution of the company's RECAF test is "still in its infancy"."